Frontlight ResearchEarly access
Pancreatic cancer trials in United States
405 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Where
- Atlanta, Columbus, Falls Church, Grand Rapids, Houston, La Jolla, Mineola, New York, Scottsdale, West Valley City
- Age
- 18 years and over
- People
- 575 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06400472 · EU 2024-511238-11-00 - Phase 1Taking peopleA Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Where
- Atlanta, Boston, Chicago, Cleveland, Denver, Duarte, Grand Rapids, Houston, Indianapolis, La Jolla, Los Angeles, Nashville, New York, Salt Lake City, San Antonio, St Louis, St. Petersburg, West Valley City
- Age
- 18 years and over
- People
- 460 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06465069 · EU 2024-512927-36-00 - Phase 2Taking peopleA Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
- Where
- Amarillo, Chicago Ridge, Dallas, Detroit, Fort Myers, Horsham, Houston, Knoxville, Lake Success, Littleton, Nashville, New York, Orlando, Prescott, Roanoke, San Antonio, St. Petersburg, West Palm Beach, Westwood
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT06695845 · EU 2024-516551-41-00 - Phase 2Taking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Birmingham, Boston, Cleveland, Detroit, Duarte, Farmington Hills, Fort Myers, Houston, Madison, Nashville, Seattle
- Age
- 18 years and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - No phaseTaking peopleDistance-Based Exercise to Preserve Function and Prevent Disability
- Where
- Boston, Butler, Cranberry Township, Dublin, Fremont, Fresno, Indiana, Kernersville, Mechanicsville, Midlothian, Modesto, Mount Airy, New Castle, Oakland, Pittsburgh, Richmond, Sacramento, San Francisco, San Jose, San Rafael, Santa Clara, Santa Rosa, Seneca, Vallejo, Walnut Creek, Winston-Salem
- Age
- 18 years and over
- People
- 104
- Run by
- Alliance for Clinical Trials in Oncology
See details and how to joinNCT07059884 - Phase 1Taking peopleA Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Where
- Boston, Dallas, Detroit, Durham, Glen Burnie, Grand Rapids, Houston, Indianapolis, Madison, Miami, Newport Beach, New York, Philadelphia, Rochester, Stanford, St Louis, Tampa
- Age
- 18 years and over
- People
- 340 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07213791 · EU 2025-521887-37-00 - Phase 2Taking peopleA Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Where
- Ann Arbor, Atlanta, Aurora, Baltimore, Boston, Buffalo, Durham, Houston, Madison, New York, Rochester, San Francisco, Seattle
- Age
- 18 years and over
- People
- 254 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07492680 - Phase 1/2Taking peopleAdministering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
- Where
- Bethesda
- Age
- 18 years to 72 years
- People
- 110
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03190941 - Phase 1Taking peopleIntraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis
- Where
- Aurora
- Age
- 18 years and over
- People
- 10
- Run by
- University of Colorado, Denver
See details and how to joinNCT07030283 - Phase 3Taking peopleA Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
- Where
- Ann Arbor, Atlanta, Baltimore, Basking Ridge, Billings, Buffalo, Charlottesville, Columbus, Commack, Dallas, Detroit, Edgewood, Fairfax, Fort Smith, Fullerton, Gilbert, Harrison, Hartford, Houston, Indianapolis, Irvine, Jacksonville, Lebanon, Los Angeles, Miami, Miami Beach, Middletown, Mineola, Minneapolis, Montvale, Morristown, Newport Beach, New York, Oklahoma City, Orange, Orlando, Pittsburgh, Portland, Providence, Rochester, Saint Louis Park, Saint Paul, Salt Lake City, Seattle, Springfield, St Louis, Stony Brook, Tucson, Uniondale, White Plains
- Age
- 18 years and over
- People
- 614 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07409272 · EU 2025-523684-38-00 - Phase 1Not yet taking people in United StatesA Study of MC001 in Patients With Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) and Other Folate Receptor Alpha (FRα)-Expressing Solid Tumors
- Where
- Fairfax, Huntersville, San Antonio, Syracuse
- Age
- 18 years and over
- People
- 40
- Run by
- Medicovestor, Inc
See details and how to joinNCT07909356 - Phase 1Taking peopleM0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors
- Where
- New Haven, New York, San Antonio
- Age
- 18 years and over
- People
- 77 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07166601 - Phase 1/2Not yet taking people in United StatesA Study of Perioperative Navlimetostat Combined With Modified FOLFIRINOX in Patients With MTAP-Deleted Pancreatic Cancer
- Where
- Durham
- Age
- 18 years and over
- People
- 18
- Run by
- Daniel Nussbaum, M.D.
See details and how to joinNCT07905131 - No phaseTaking peopleThe Use of Contrast Enhanced Ultrasound (CEUS) In Post-Surgical Pancreatic Cancer Patients to Evaluate Local Disease Recurrence
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 10
- Run by
- Thomas Jefferson University
See details and how to joinNCT07910383 - Phase 2/3Taking peopleZanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Where
- Albuquerque, Bethesda, Beverly Hills, Birmingham, Boston, Buffalo, Chapel Hill, Charlottesville, Cleveland, Columbus, Dallas, Detroit, Durham, Fairfax, Fargo, Grand Rapids, Jacksonville, Knoxville, Lexington, Los Angeles, Metairie, Milwaukee, Nashville, New York, Omaha, Orlando, Palo Alto, Philadelphia, Phoenix, Pittsburgh, Portland, Rochester, Salt Lake City, Santa Monica, Seattle, St Louis, Tampa, Tucson, Vallejo, Washington D.C.
- Age
- 18 years and over
- People
- 440 worldwide
- Run by
- Exelixis
See details and how to joinNCT06943755 · EU 2025-521043-20-00 - Phase 1Taking peopleA Study of MGC030 in Participants With Advanced Solid Tumors
- Where
- Lake Success
- Age
- 18 years and over
- People
- 314
- Run by
- MacroGenics
See details and how to joinNCT07822399 - No phaseTaking peopleObtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
- Where
- Bethesda
- Age
- 2 years and over
- People
- 1,800
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT01915225 - Phase 1/2Taking peopleAdministering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- Where
- Bethesda
- Age
- 18 years to 72 years
- People
- 124
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT02830724 - No phaseTaking peoplePancreatic Cancer Early Detection Consortium
- Where
- Ann Arbor, Atlanta, Bloomington, Boston, Burbank, Charlottesville, Chicago, Columbus, Dallas, Duarte, Evanston, Fairfax, Hackensack, Houston, Jacksonville, Kansas City, Knoxville, La Jolla, Los Angeles, Miami, Midlothian, New Haven, Newport Beach, New York, Omaha, Orange, Philadelphia, Phoenix, Pittsburgh, Portland, Richmond, Rochester, Royal Oak, Sacramento, Salt Lake City, San Francisco, Scottsdale, Seattle, St. George, Tampa, White Plains, Worcester
- Age
- 18 years to 90 years
- People
- 20,000 worldwide
- Run by
- Arbor Research Collaborative for Health
See details and how to joinNCT04970056 - Phase 1/2Taking peopleA Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- Where
- Aurora, Gainesville, Houston, Los Angeles, Madison, Marietta, Miami Beach, Mineola, New York, Roanoke, Washington D.C.
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06428409 · EU 2023-508703-21-00 - Phase 2Taking people18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 320
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06503146 - No phaseTaking peopleAdaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 16
- Run by
- Fox Chase Cancer Center
See details and how to joinNCT06984562 - Phase 1Taking peopleA Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
- Where
- Atlanta, Buffalo, Cleveland, Fairfax, Grand Rapids, Hackensack, Irving, Jefferson, New York, Santa Monica, St Louis
- Age
- 18 years and over
- People
- 404 worldwide
- Run by
- Astellas Pharma Inc
See details and how to joinNCT07094204 · EU 2025-522082-29-00 - Early phase 1Taking peoplePilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer
- Where
- New Hyde Park
- Age
- 18 years and over
- People
- 10
- Run by
- Northwell Health
See details and how to joinNCT07254091 - Phase 1Taking peopleSamuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer
- Where
- Seattle
- Age
- 18 years and over
- People
- 15
- Run by
- University of Washington
See details and how to joinNCT07645651